Filing Flows › AbCellera Biologics (ABCL) › Licensing and royalty revenue revenue
AbCellera Biologics (ABCL) Licensing and royalty revenue revenue by quarter
AbCellera Biologics' Licensing and royalty revenue revenue was $90K in Q3 2026 (third quarter 2026), -40% from Q2 2026. Over the last 3 quarters it ranged from $90K (Q3 2026) to $191K (Q1 2026).
| Quarter | Licensing and royalty revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $90K | -40% | — |
| Q2 2026 | $149K | -22% | — |
| Q1 2026 | $191K | — | — |
Q3 2026 at a glance
AbCellera Biologics, Q3 2026: revenue $10.6M (+19% year over year), operating margin -501.1%, net loss $40.8M, operating cash flow $26.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is AbCellera Biologics' Licensing and royalty revenue revenue?
AbCellera Biologics' Licensing and royalty revenue revenue was $90K in Q3 2026 (third quarter 2026), -40% from Q2 2026.
How has AbCellera Biologics' Licensing and royalty revenue revenue changed?
Over the last 3 quarters it ranged from $90K (Q3 2026) to $191K (Q1 2026).